26th Mar 2008 14:00
AstraZeneca PLC26 March 2008 Transaction by Persons Discharging Managerial Responsibilities Disclosure Rules DTR 3.1.4R We hereby inform you that the interest of David R. Brennan, a Director of theCompany, in the shares of AstraZeneca PLC has changed as detailed below. MrBrennan has interests in both the Ordinary Shares and the American DepositaryShares (ADSs) of AstraZeneca PLC. One ADS equals one Ordinary Share. On 24 March 2008, Mr Brennan became unconditionally entitled to a final award of26,762 ADSs on the partial vesting of a previously announced original targetaward of 27,877 ADSs, which were awarded to him in March 2005 under the terms ofthe AstraZeneca US Executive Performance Share Plan. Mr Brennan has ceased tohave an interest in the 1,115 ADSs of the original target award that did notvest. After certain mandatory tax deductions, Mr Brennan has received 17,715ADSs into a personal brokerage account. The closing price of AstraZeneca ADSs on 20 March 2008 was US$37.63. Immediately prior to the above transactions, Mr Brennan had an interest in234,428 Ordinary Shares and 121,435 AstraZeneca ADSs. As a result of thesetransactions, Mr Brennan now has an interest in 234,428 Ordinary Shares and111,273 AstraZeneca ADSs. This interest represents approximately 0.024% of theCompany's issued ordinary capital. G H R MuskerCompany Secretary26 March 2008 This information is provided by RNS The company news service from the London Stock ExchangeRelated Shares:
Astrazeneca